Oct 9, 2026 03:22AM
Jan 14, 2025 07:00AM
Jan 14, 2025 07:00AM
Jan 8, 2025 07:00AM
Jan 29, 2024 04:27AM
Jan 9, 2024 04:01PM
Jan 9, 2024 04:01PM C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
Jan 4, 2024 07:00AM
Jan 9, 2023 07:00AM
Jan 9, 2023 07:00AM
Jan 3, 2023 07:00AM
Jan 3, 2023 07:00AM
Nov 4, 2022 06:11AM
Mar 10, 2022 04:23AM UPDATE: JPMorgan Starts C4 Therapeutics (CCCC) at Overweight
Jan 10, 2022 07:03AM
Jan 10, 2022 07:00AM
Jan 10, 2022 07:00AM
Jan 3, 2022 07:00AM
Jan 3, 2022 07:00AM
Jun 21, 2021 04:01PM
Jun 21, 2021 04:01PM C4 Therapeutics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Jun 17, 2021 06:08AM
Jun 16, 2021 07:51PM
Jun 16, 2021 07:51PM
Jun 14, 2021 04:13PM
Jun 14, 2021 04:12PM
Jun 14, 2021 04:12PM
Jan 7, 2021 07:00AM C4 Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Jan 7, 2021 07:00AM
Jan 6, 2021 07:00AM
Jan 6, 2021 07:00AM

301,139 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All